PNC Financial Services Group’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.79K | Buy |
|
|||||
|
2025
Q1 | $624 | Buy |
|
|||||
|
2024
Q4 | $460 | Sell |
|
|||||
|
2024
Q3 | $680 | Hold |
|
|||||
|
2024
Q2 | $819 | Buy |
|
|||||
|
2024
Q1 | $210 | Sell |
|
|||||
|
2023
Q4 | $354 | Sell |
|
|||||
|
2023
Q3 | $14.3K | Sell |
|
|||||
|
2023
Q2 | $25.1K | Sell |
|
|||||
|
2023
Q1 | $53.1K | Sell |
|
|||||
|
2022
Q4 | $67.8K | Buy |
|
|||||
|
2022
Q3 | $63K | Sell |
|
|||||
|
2022
Q2 | $95K | Buy |
|
|||||
|
2022
Q1 | $59K | Sell |
|
|||||
|
2021
Q4 | $89K | Buy |
|
|||||
|
2021
Q3 | $44K | Sell |
|
|||||
|
2021
Q2 | $68K | Buy |
|
|||||
|
2021
Q1 | $43K | Buy |
|
|||||
|
2020
Q4 | $32K | Buy |
|
|||||
|
2020
Q3 | $17K | Sell |
|
|||||
|
2020
Q2 | $27K | Buy |
|
|||||
|
2020
Q1 | $17K | Sell |
|
|||||
|
2019
Q4 | $50K | Buy |
|
|||||
|
2019
Q3 | $24K | Sell |
|
|||||
|
2019
Q2 | $1.87M | Sell |
|
|||||
|
2019
Q1 | $3.1M | Sell |
|
|||||
|
2018
Q4 | $9.06M | Buy |
|
|||||
|
2018
Q3 | $6.41M | Buy |
|
|||||
|
2018
Q2 | $4.26M | Sell |
|
|||||
|
2018
Q1 | $3.81M | Sell |
|
|||||
|
2017
Q4 | $6.09M | Buy |
|
|||||
|
2017
Q3 | $6.24M | Buy |
|
|||||
|
2017
Q2 | $5.2M | Buy |
|
|||||
|
2017
Q1 | $4.39M | Buy |
|
|||||
|
2016
Q4 | $4.5M | Buy |
|
|||||
|
2016
Q3 | $4.37M | Buy |
|
|||||
|
2016
Q2 | $11K | Hold |
|
|||||
|
2016
Q1 | $8K | Hold |
|
|||||
|
2015
Q4 | $9K | Sell |
|
|||||
|
2015
Q3 | $12K | Buy |
|